COLGATE PALMOLIVE CO

CL 10-Q · Q3 2025
API behind this page

CL Q3 2025 request

Playground key active
Request URL /api/financials?ticker=CL&year=2025&quarter=3
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q3 2025 Q3 2024 YoY
Revenue 5,131 5,033 +1.9%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 297 278 +6.8%
Oral, Personal and Home Care · Asia Pacific 714 725 -1.5%
Oral, Personal and Home Care · Europe 801 744 +7.7%
Oral, Personal and Home Care · Latin America 1,178 1,156 +1.9%
Oral, Personal and Home Care · North America 999 1,004 -0.5%
Oral, Personal and Home Care · Operating Segments 3,989 3,907 +2.1%
Pet Nutrition · Operating Segments 1,142 1,126 +1.4%
Cost of Revenue 2,082 1,959 +6.3%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 118 109 +8.3%
Oral, Personal and Home Care · Asia Pacific 270 269 +0.4%
Oral, Personal and Home Care · Europe 300 275 +9.1%
Oral, Personal and Home Care · Latin America 541 459 +17.9%
Oral, Personal and Home Care · North America 398 381 +4.5%
Pet Nutrition · Operating Segments 457 463 -1.3%
Gross Profit 3,049 3,074 -0.8%
Selling, General & Administrative 1,971 1,979 -0.4%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 106 99 +7.1%
Oral, Personal and Home Care · Asia Pacific 264 264 0.0%
Oral, Personal and Home Care · Europe 285 280 +1.8%
Oral, Personal and Home Care · Latin America 303 325 -6.8%
Oral, Personal and Home Care · North America 401 409 -2.0%
Pet Nutrition · Operating Segments 427 406 +5.2%
Other Operating Income Expense Net 19 30 -36.7%
Operating Income 1,059 1,065 -0.6%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 68 65 +4.6%
Oral, Personal and Home Care · Asia Pacific 188 199 -5.5%
Oral, Personal and Home Care · Europe 209 181 +15.5%
Oral, Personal and Home Care · Latin America 337 365 -7.7%
Oral, Personal and Home Care · North America 190 206 -7.8%
Oral, Personal and Home Care · Operating Segments 992 1,016 -2.4%
Pet Nutrition · Operating Segments 255 258 -1.2%
Show Consolidation Items breakouts
Corporate Non Segment -189 -208 +9.1%
Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component 21 23 -8.7%
Interest Expense 67 74 -9.5%
Investment Income Interest And Dividend 21 18 +16.7%
Income Before Taxes 992 986 +0.6%
Income Tax Expense (Benefit) 226 210 +7.6%
Net Income 766 776 -1.3%
Show Equity Components breakouts
Noncontrolling Interest 31 39 -20.5%
Retained Earnings 735 737 -0.3%
Net Income Loss Attributable To Noncontrolling Interest 31 39 -20.5%
Net Income 735 737 -0.3%
EPS (Basic) 0.91 0.9 +1.1%
EPS (Diluted) 0.91 0.9 +1.1%
Comprehensive Income 771 792 -2.7%
Wtd Avg Shares (Basic) 807.8 817.7 -1.2%
Wtd Avg Shares (Diluted) 810.2 822.5 -1.5%
Net Income Loss Available To Common Stockholders Basic 735 737 -0.3%

Balance Sheet

Balance Sheet
Metric Q3 2025 Q3 2024 YoY
Current Assets
Cash & Cash Equivalents 1,279 1,234 +3.6%
Accounts Receivable 1,807 1,712 +5.5%
Inventory 2,109 — —
Other Assets Current 844 819 +3.1%
Total Current Assets 6,039 5,806 +4.0%
Non-Current Assets
Property, Plant & Equipment 4,560 4,421 +3.1%
Goodwill 3,702 — —
Deferred Tax Assets 216 219 -1.4%
Other Non-Current Assets 1,107 1,105 +0.2%
Total Assets 17,513 16,774 +4.4%
Other Assets
Property Plant And Equipment Gross 10,847 10,238 +5.9%
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment -6,287 -5,817 -8.1%
Intangible Assets Net Excluding Goodwill 1,889 1,834 +3.0%
Current Liabilities
Short Term Bank Loans And Notes Payable 1,113 507 +119.5%
Accounts Payable 1,866 1,625 +14.8%
Accrued Income Taxes Current 339 347 -2.3%
Other Accrued Liabilities Current 3,178 3,066 +3.7%
Total Current Liabilities 6,496 5,565 +16.7%
Non-Current Liabilities
Long-Term Debt 7,306 7,909 -7.6%
Deferred Tax Liabilities 304 320 -5.0%
Other Non-Current Liabilities 2,169 2,144 +1.2%
Total Liabilities 16,275 15,938 +2.1%
Long-Term Debt (Q) — — —
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 8,419 7,929 +6.2%
Stockholders' Equity
Common Stock 1,466 1,466 0.0%
Additional Paid-In Capital 4,284 4,142 +3.4%
Retained Earnings 27,051 25,814 +4.8%
Accumulated Other Comprehensive Income -3,888 -4,074 +4.6%
Treasury Stock Common Value -28,057 -26,913 -4.3%
Total Stockholders' Equity 856 435 +96.8%
Minority Interest 382 401 -4.7%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1,238 836 +48.1%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -3,888 -4,074 +4.6%
Additional Paid In Capital 4,284 4,142 +3.4%
Common Stock 1,466 1,466 0.0%
Noncontrolling Interest 382 401 -4.7%
Retained Earnings 27,051 25,814 +4.8%
Treasury Stock Common -28,057 -26,913 -4.3%
Total Liabilities & Equity 17,513 16,774 +4.4%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2025 YTD Q3 2024 YoY
Operating Activities
Depreciation & Amortization 457 457 0.0%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 7 6 +16.7%
Oral, Personal and Home Care · Asia Pacific 59 60 -1.7%
Oral, Personal and Home Care · Europe 48 49 -2.0%
Oral, Personal and Home Care · Latin America 78 77 +1.3%
Oral, Personal and Home Care · North America 92 93 -1.1%
Oral, Personal and Home Care · Operating Segments 284 285 -0.4%
Pet Nutrition · Operating Segments 98 100 -2.0%
Show Consolidation Items breakouts
Corporate Non Segment 75 72 +4.2%
Litigation Settlement Expense 65 — —
Show Retirement Plan Type breakouts
Pension Plans Defined Benefit · US 50 — —
Restructuring Net Of Cash -15 54 -127.8%
Stock-Based Compensation 127 108 +17.6%
Deferred Income Taxes And Tax Credits 8 -98 +108.2%
Increase Decrease In Receivables -180 -184 +2.2%
Change in Inventory 9 -94 +109.6%
Increase Decrease In Accounts Payable And Accrued Liabilities 30 327 -90.8%
Increase Decrease In Other Operating Capital Net -22 -2 -1000.0%
Net Cash from Operations 2,745 2,838 -3.3%
Investing Activities
Payments To Acquire Productive Assets -387 -377 -2.7%
Payments To Acquire Marketable Securities -537 -358 -50.0%
Proceeds From Sale And Maturity Of Marketable Securities 508 260 +95.4%
Payments For Proceeds From Businesses And Interest In Affiliates -293 — —
Other Investing Activities -5 21 -123.8%
Net Cash from Investing -714 -454 -57.3%
Financing Activities
Proceeds From Repayments Of Short Term Debt 139 337 -58.8%
Repayments Of Other Debt -655 -502 -30.5%
Proceeds From Other Debt 497 2 +24750.0%
Payments Of Ordinary Dividends -1,300 -1,275 -2.0%
Share Repurchases -804 -1,284 +37.4%
Proceeds From Stock Options Exercised 83 611 -86.4%
Proceeds From Payments For Other Financing Activities 145 1 +14400.0%
Net Cash from Financing -1,895 -2,110 +10.2%
Supplemental
Income Taxes Paid 712 762 -6.6%
Interest Paid 235 267 -12.0%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 47 -6 +883.3%
Net Change in Cash 183 268 -31.7%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,279 1,234 +3.6%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key